Evidence map›Paper›PMID 40854117›Full record

SynthesisPain medicine (Malden, Mass.)2026

Evidence-based framework for identifying opioid use disorder in administrative data: A systematic review and methodological development study.

Robert W Hurley, Khadijah T Bland, Mira D Chaskes, Daniel Guth, Elaine L Hill, Meredith C B Adams

Abstract readSystematic Review
In one paragraph

Synthesis in Pain medicine (Malden, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robert W HurleyDepartment of Anesthesiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, United States.ORCID 0000-0001-6591-9390
Khadijah T BlandDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, 14642, United States.ORCID 0009-0002-8693-0454
Mira D ChaskesDepartment of Economics, Massachusetts Institute of Technology, Cambridge, MA, United States.ORCID 0009-0004-3499-9753
Daniel GuthDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, 14642, United States.ORCID 0000-0003-0937-5282
Elaine L HillDepartment of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, 14642, United States.ORCID 0000-0003-2494-317X
Meredith C B AdamsDepartment of Anesthesiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, United States.ORCID 0000-0002-3969-4279

Funding

Increasing Participant Diversity in a 'Sequenced-Strategy to Improve Outcomes in people with Knee Osteoarthritis Pain (SKOAP)UH3AR077360 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CAMPBELL, CLAUDIA MICHELLE, CASTILLO, RENAN C · 2020 to 2023
$13.8M
MIRHIQL Resource Center for Improving Quality of Life with Chronic Pain (MRC)R24DA058606 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ADAMS, MEREDITH C. B., HURLEY, ROBERT WILLSON · 2023 to 2023
$6.0M
WF DISC: Navigating Data Solutions for Chronic Pain and Opioid Use DisorderU24DA057612 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MEREDITH C. B. ADAMS · 2022 to 2026
$5.6M
Economic Conditions, Policy Environments, and Opioid Use Disorder U01DA057016 · NIDA · UNIVERSITY OF ROCHESTER · PI MEREDITH C. B. ADAMS, Elaine L Hill · 2022 to 2026
$3.6M
Wake Forest IMPOWR Dissemination Education and Coordination Center (IDEA-CC)R24DA055306 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ADAMS, MEREDITH C. B. · 2021 to 2023
$3.3M
HEAL InitiativeNational Institute for Drug Abuse R24DA055306National Institute for Drug Abuse R24DA058606National Institute for Drug Abuse U01DA057016National Institute for Drug Abuse U24DA057612NIAMS NIH HHS UH3 AR077360NIDA NIH HHS R24 DA055306NIDA NIH HHS R24 DA058606NIDA NIH HHS U01 DA057016NIDA NIH HHS U24 DA057612NIH HHSNIH HHS UH3AR077360
6 · The paper itself

Abstract

objectiveTo systematically evaluate existing approaches for identifying opioid use disorder (OUD) in administrative data sets and develop evidence-based recommendations for standardized identification methods.

designSystematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Scoping Review guidelines with comprehensive literature search and evidence synthesis for framework development.

settingAdministrative data sets including commercial claims, Medicaid, Medicare, and electronic health records. SUBJECTS: In brief, 169 studies using administrative codes to identify OUD, primarily from US healthcare systems (94.7%).

methodsSystematic search of EMBASE, MEDLINE, Google Scholar, and PubMed through February 2024. Three independent reviewers screened articles and extracted data using standardized tools. Study quality was assessed using modified Newcastle-Ottawa Scale. Framework development employed systematic integration of evidence-based components from high-quality studies.

resultsOur analysis of 169 studies revealed four distinct identification approaches: Direct diagnosis codes (36.7%), composite definitions (48.0%), overdose codes (10.1%), and medication-assisted treatment codes (1.2%). Commercial claims data predominated (60.4%), followed by Medicaid claims (10.1%) and electronic health records (7.7%). Multi-modal strategies incorporating both diagnostic and treatment codes showing superior theoretical foundation compared to single-method approaches. Substantial variation existed in reference periods, code requirements, and treatment verification approaches.

conclusionsAn evidence-based framework incorporating diagnosis codes, specific temporal requirements, validated indirect indicators, and treatment evidence provides theoretical foundation for standardized OUD identification protocols. The framework addresses known sources of misclassification while maintaining diagnostic specificity through clinical diagnostic alignment and systematic validation research programs. REGISTRATION: Prospero (CRD42023406173) and OSF (osf.io/ru4j3).

Indexed as

Opioid-Related DisordersElectronic Health RecordsEvidence-Based MedicineHumansUnited Statesadministrative datadiagnostic codinghealth services researchICD-10opioid use disordersystematic review

Identifiers

PMID40854117
PMCPMC12865102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.